Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia

NCT06176456 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

60

Enrollment

OTHER_GOV

Sponsor class

Conditions

Catatonia
Schizophrenia
Schizo Affective Disorder
Bipolar Affective Disorder

Interventions

DIAGNOSTIC_TEST: rTMS
OTHER: Placebo

Sponsor

Moscow Psychiatric Hospital No. 1 Named after N.A. Alexeev